|
The Centre for Molecular Medicine and Therapeutics (CMMT) is part of the University of British Columbia's Faculty of Medicine. The Centre is located at the Child & Family Research Institute (CFRI) in Vancouver, Canada. Research at the centre is focused on discovering genetic susceptibility to illnesses such as Huntington Disease, Type 2 diabetes and bipolar disorder. In 2008, the director and founder of the Centre, Dr. Michael Hayden, was named "Researcher of the Year" by the Canada Institutes of Health Research. In 2011, he was appointed to the Order of Canada in 2011 for his contributions to Huntington's Disease research. Principal investigators within the Centre are involved in other initiatives. Dr. Daniel Goldowitz is the Scientific Director of NeuroDevNet, which is a Canada Networks of Centres of Excellence. The life sciences research laboratory consists of over 200 staff, eight of whom are UBC faculty members. Four of the principal investigators at the Centre are Canada Research Chairs. == Key achievements == *1999 – ABCA1 a key regulator of high-density_lipoprotein in humans is discovered *2003 – LPL deficiency is cured in animal models *2004 – Open-access JASPAR database is released - a fundamental resource for studying gene regulation *2005 – Gene networks analysis algorithm published *2006 – Huntington Disease is treated in mouse model *2006 – The genetic cause of codeine-induced adverse drug reaction causing infant death is 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Centre for Molecular Medicine and Therapeutics」の詳細全文を読む スポンサード リンク
|